Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Advanced Solid Tumors 357Unspecified Adult Solid Tumor, Protocol Specific 302Advanced Solid Tumor 274Solid Tumor 237Solid Tumors 233Mesothelioma 84Mesothelioma, Malignant 79Solid Tumor, Adult 65Carcinoma, Non-Small-Cell Lung 57Ovarian Neoplasms 38Melanoma 35Lung Neoplasms 29Advanced or Metastatic Solid Tumors 27Neoplasms 26Carcinoma, Renal Cell 26Uterine Cervical Neoplasms 25Stomach Neoplasms 25Pancreatic Neoplasms 25Solid Tumours 24Sarcoma 24Colorectal Neoplasms 24Retinoblastoma 22Esophageal Neoplasms 22Advanced Malignant Solid Tumors 22Unspecified Childhood Solid Tumor, Protocol Specific 21Squamous Cell Carcinoma of Head and Neck 20Breast Neoplasms 20Advanced Solid Tumours 20Triple Negative Breast Neoplasms 19Small Cell Lung Carcinoma 19

Interventions

osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Hemangioendothelioma, Epithelioid × Other solid neoplasm × Clear all
NCT05228015 2024-11-18

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Ikena Oncology

Phase 1 Terminated
67 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Hemangioendothelioma, Epithelioid

NCT06452160 2024-08-09

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

BridGene Biosciences Inc.

Phase 1 Recruiting
103 enrolled
Other solid neoplasmThoracic

Mesothelioma, Hemangioendothelioma, Epithelioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡